Danone North America Issues Allergy Alert and Recall for Light & Fit Greek Crunch S’mores FlavorApril 26, 2019
Inspired Organics Issues Voluntary Recall of Organic Sunflower Butter Due to Potential Health RiskApril 26, 2019
Updated: Torrent Pharmaceuticals Limited Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP and Losartan Potassium/Hydrochlorothiazide Tablets, USPApril 26, 2019
Teva Pharmaceuticals USA, Inc. Issues Voluntary Nationwide Recall of Losartan Potassium 25 mg and 100 mg Tablets USP, Sold Exclusively to Golden State Medical SupplyApril 26, 2019
FDA launches public education campaign to encourage safe removal of unused opioid pain medicines from homesApril 25, 2019
Legacy Pharmaceutical Packaging, LLC Expands Voluntary Nationwide Recall of Losartan Potassium Tablets, USP, 50mg Due to the Detection of Trace Amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA) Impurity Found in the Active Pharmaceutical Ingredient (API)April 24, 2019
Jurox Incorporated is Voluntarily Recalling Two Lots of Alfaxan Unpreserved, an Intravenous Injectable AnaestheticApril 24, 2019
Statement from Jeffrey Shuren, M.D., J.D., Director of the FDA’s Center for Devices and Radiological Health, on new steps to help reduce risks associated with surgical staplers for internal use and implantable staplesApril 23, 2019
Statement from FDA Associate Commissioner for Regulatory Affairs Melinda K. Plaisier, on agency’s new steps to strengthen the process of initiating voluntary recallsApril 23, 2019
Statement from Peter Marks, M.D., Ph.D., director of FDA’s Center for Biologics Evaluation and Research, on FDA’s continued confidence in the safety and effectiveness of the measles, mumps, and rubella (MMR) vaccineApril 22, 2019
Alvogen Inc. Issues Voluntary Nationwide Recall of Fentanyl Transdermal System Due to Product MislabelingApril 21, 2019
